PERSONALISED BIOMARKER JOURNALS
Hulka defined biomarker because the cellular, biochemical or molecular alterations that are measurable in biological cells like human tissues, cells, or fluids. Biomarkers sometimes function intermediate markers and also as drug targets in clinical trials. the method by which the biomarkers are discovered is termed as biomarker discovery. The identification of tumor biomarkers is that the initiative in personalizing medicine. So supported the action of bio markers, they're of various types. A journal may be a periodical publication intended to further progress of science, usually by reporting new research. Journals contain articles that peer reviewed, in an effort to make sure that articles meet the journal's standards of quality, and scientific validity. Each such journal article becomes a part of the permanent scientific record.
• The aim of the journal is to furnish the newest , emerging and most comprehensive global outlook while projecting the sensible implications of the recent advances in experimental and clinical pharmacology with an ultimate vision of facilitating the event of safe and effective drugs and drug regulation policies.
• The journal covers a good range of topics regarding drug dependence and addiction; epidemiological and cohort studies on drug effects; impact of organic phenomenon pattern and polymorphisms on drug effects; drug effects on different systems, etc.
• The Journal intends to supply a transparent and concise presentation of theoretical perspective, expert opinions and comments on then-current and emerging challenges in experimental and clinical pharmacology. • The articles are published under The Creative Commons User License (CC BY-NC 4.0) permits third party reuse.
High Impact List of Articles
-
Conference Announcement of the International Conference on Medical and Health Sciences
Luis Ayala2020 Conference Announcement: Biology & Medicine Case Reports
-
Conference Announcement of the International Conference on Medical and Health Sciences
Luis Ayala2020 Conference Announcement: Biology & Medicine Case Reports
-
A computational approach to identify microRNA (miRNA) based biomarker from the regulation of disease pathology
Anandaram HResearch Article: Biology & Medicine Case Reports
-
A computational approach to identify microRNA (miRNA) based biomarker from the regulation of disease pathology
Anandaram HResearch Article: Biology & Medicine Case Reports
-
The importance of quality protein food in the treatment of fractures of tibia.
Schurov VA and Schurov IVOriginal Article: Biology & Medicine Case Reports
-
The importance of quality protein food in the treatment of fractures of tibia.
Schurov VA and Schurov IVOriginal Article: Biology & Medicine Case Reports
-
Therapeutic Strategies for Liver Abscess
Zhang J, Kong CJ, Zhong Jia*, Chen MQ, Liang-Liang FangImaging Brain: Biology & Medicine Case Reports
-
Therapeutic Strategies for Liver Abscess
Zhang J, Kong CJ, Zhong Jia*, Chen MQ, Liang-Liang FangImaging Brain: Biology & Medicine Case Reports
-
Analysis of myocardial infarction risk factors in heart disease data set
Chitra R, Chenthil Jegan TM, Ezhilarasu RReview Article: Biology & Medicine Case Reports
-
Analysis of myocardial infarction risk factors in heart disease data set
Chitra R, Chenthil Jegan TM, Ezhilarasu RReview Article: Biology & Medicine Case Reports
Conference Proceedings
-
A NOVEL LYMPHOABLATION PRECONDITIONING AGENT (AVM0703) VIA RECEPTOR MEDIATED INDUCTION OF APOPTOSIS TO REDUCE PATIENT TOXICITIES PRIOR TO CART THERAPY OR STEM CELL TRANSPLANTS TO REDUCE TOXICITIES AND IMPROVE PATIENT SAFETY
Theresa A Deisher -
A NOVEL LYMPHOABLATION PRECONDITIONING AGENT (AVM0703) VIA RECEPTOR MEDIATED INDUCTION OF APOPTOSIS TO REDUCE PATIENT TOXICITIES PRIOR TO CART THERAPY OR STEM CELL TRANSPLANTS TO REDUCE TOXICITIES AND IMPROVE PATIENT SAFETY
Theresa A Deisher -
Evaluation of classical and novel von Willebrand Factor assays in ECLM defined von Willebrand disease patients
Jan MichielsKeynote: Hematology and Blood Disorders
-
Evaluation of classical and novel von Willebrand Factor assays in ECLM defined von Willebrand disease patients
Jan MichielsKeynote: Hematology and Blood Disorders
-
Ti-Si alloys - Materials for implants applications
Sulikova MPosters & Accepted Abstracts: Biomedical Research
-
Ti-Si alloys - Materials for implants applications
Sulikova MPosters & Accepted Abstracts: Biomedical Research
-
Synthesis of metallacarboranes-based delocalized lipophilic cations for diagnostics and Cancer treatment
Dugin Sergey, P Belov, E Gurkova, V Pasko and P StorozhenkoPosters & Accepted Abstracts: Journal of Medical Oncology and Therapeutics
-
Synthesis of metallacarboranes-based delocalized lipophilic cations for diagnostics and Cancer treatment
Dugin Sergey, P Belov, E Gurkova, V Pasko and P StorozhenkoPosters & Accepted Abstracts: Journal of Medical Oncology and Therapeutics
-
IMMUNOLOGICAL ASPECTS OF SUBLINGUAL AND SUBCUTANEOUS ALLERGEN-SPECIFIC IMMUNOTHERAPY
Nerin Nadir Bahceciler OnderPosters & Accepted Abstracts: Asian Journal of Biomedical and Pharmaceutical Sciences
-
IMMUNOLOGICAL ASPECTS OF SUBLINGUAL AND SUBCUTANEOUS ALLERGEN-SPECIFIC IMMUNOTHERAPY
Nerin Nadir Bahceciler OnderPosters & Accepted Abstracts: Asian Journal of Biomedical and Pharmaceutical Sciences
-
BCL-XL DIRECTLY MODULATES RAS SIGNALLING TO FAVOUR CANCER CELL STEMNESS
Philippe Juin -
BCL-XL DIRECTLY MODULATES RAS SIGNALLING TO FAVOUR CANCER CELL STEMNESS
Philippe Juin -
Discussion on the value of combined hs-TnT and NT-proBNP with ultra-window stable of STEMI patient′s risk of stratification and prognosis in direct percutaneous coronary intervention
Lao YiPosters & Accepted Abstracts: Journal of Medical Oncology and Therapeutics
-
Discussion on the value of combined hs-TnT and NT-proBNP with ultra-window stable of STEMI patient′s risk of stratification and prognosis in direct percutaneous coronary intervention
Lao YiPosters & Accepted Abstracts: Journal of Medical Oncology and Therapeutics
-
Decoding of non-coding DNA and non-coding RNA: Noncoding RNA-encoded novel peptides/proteins regulate migration of cancer cells
E Shyam P Reddy -
Decoding of non-coding DNA and non-coding RNA: Noncoding RNA-encoded novel peptides/proteins regulate migration of cancer cells
E Shyam P Reddy